Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Nevro Corp ( (NVRO) ) has issued an announcement.
Nevro Corp. has entered into a merger agreement with Globus Medical, which will acquire all shares of Nevro for $5.85 per share in an all-cash transaction valued at approximately $250 million. The merger, announced on February 6, 2025, is expected to close in the second quarter of 2025, aiming to expand Globus Medical’s market presence and improve Nevro’s financial performance through operational efficiencies. The transaction has been approved by the boards of both companies and offers a premium to Nevro’s recent stock prices. It will require regulatory and shareholder approvals, and comes with customary conditions and termination rights, including potential termination fees.
More about Nevro Corp
Nevro Corp. is a global medical device company based in Redwood City, California, focused on providing comprehensive solutions for the treatment of chronic pain, including the HFX spinal cord stimulation platform and minimally invasive treatments for sacroiliac joint pain.
YTD Price Performance: 35.31%
Average Trading Volume: 574,835
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $188.1M
See more data about NVRO stock on TipRanks’ Stock Analysis page.
